Search

Your search keyword '"Aurelia Rughetti"' showing total 97 results

Search Constraints

Start Over You searched for: Author "Aurelia Rughetti" Remove constraint Author: "Aurelia Rughetti"
97 results on '"Aurelia Rughetti"'

Search Results

1. Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients

2. Imperative role of adaptor proteins in macrophage toll-like receptor signaling pathways

Catalog

Books, media, physical & digital resources

3. CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line

4. Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs

5. Protection of gender health and fight against gender violence during the COVID-19 pandemic: the experience of our street clinic in a disadvantaged suburb of Rome Metropolitan City

6. A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors

7. De novo transcriptome assembly and annotation of the third stage larvae of the zoonotic parasite Anisakis pegreffii

8. Proteomic characterization of extracellular vesicles released by third stage larvae of the zoonotic parasite Anisakis pegreffii (Nematoda: Anisakidae)

9. Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity

10. Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: Relief from immunosuppression is associated with clinical response

11. Immunogenic Cell Death and Immunomodulatory Effects of Cabozantinib

12. IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137+T-cells

13. Corrigendum to 'Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring'

14. Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring

15. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

16. Tumor-Derived Microvesicles Enhance Cross-Processing Ability of Clinical Grade Dendritic Cells

17. Tumor-Derived Microvesicles Modulate Antigen Cross-Processing via Reactive Oxygen Species-Mediated Alkalinization of Phagosomal Compartment in Dendritic Cells

18. The Macrophage Galactose-Type C-Type Lectin (MGL) Modulates Regulatory T Cell Functions.

19. MGL Receptor and Immunity: When the Ligand Can Make the Difference

20. Monoclonal Antibodies in Gynecological Cancer: A Critical Point of View

21. Circulating CD137+ T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients

22. Data from TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway

23. Data from Microvesicle Cargo of Tumor-Associated MUC1 to Dendritic Cells Allows Cross-presentation and Specific Carbohydrate Processing

24. Supplemental Figure 1: HLAII-DR molecule accumulates at the periphery of DCs after 12 hours incubation from Microvesicle Cargo of Tumor-Associated MUC1 to Dendritic Cells Allows Cross-presentation and Specific Carbohydrate Processing

25. Supplementary Figure 1 - PDF file - 42K from Microvesicle Cargo of Tumor-Associated MUC1 to Dendritic Cells Allows Cross-presentation and Specific Carbohydrate Processing

26. Figure S1 from TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway

27. Supplemental Figure 2: Characterization of MUC1-DG75 transfectant cell line and of the MUC1-DG75-MVs. from Microvesicle Cargo of Tumor-Associated MUC1 to Dendritic Cells Allows Cross-presentation and Specific Carbohydrate Processing

28. Supplementary Table from Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer

29. Supplementary Figure from Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer

30. Data from Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer

31. DNA response and repair gene mutations as a signature for pembrolizumab response in never-smoker non-small lung cancer: real word approach and patient similarity network analysis

32. Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer

33. Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach

34. Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma

35. Soluble PD-L1 as a prognostic factor for Immunotherapy treatment in solid tumors: systematic review and meta-analysis

36. The Role of Soluble LAG3 and Soluble Immune Checkpoints Profile in Advanced Head and Neck Cancer: A Pilot Study

37. Polymeric nanoparticles decorated with monoclonal antibodies: a new immobilization strategy for increasing lipase activity

38. Immunogenic cell death and immunomodulatory effects of cabozantinib

39. IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137+T-cells

40. Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients

41. Investigating Patterns of Immune Interaction in Ovarian Cancer: Probing the O-glycoproteome by the Macrophage Galactose-Like C-type Lectin (MGL)

42. Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma

43. Immunohistochemical Characterization of Immune Infiltrate in Tumor Microenvironment of Glioblastoma

44. The ambitious role of anti angiogenesis molecules: Turning a cold tumor into a hot one

45. Multicentre harmonisation of a six-colour flow cytometry panel for naïve/memory T cell immunomonitoring

46. Gene expression profiles of antigenic proteins of third stage larvae of the zoonotic nematode Anisakis pegreffii in response to temperature conditions

47. Bevacizumab-Based Chemotherapy Triggers Immunological Effects in Responding Multi-Treated Recurrent Ovarian Cancer Patients by Favoring the Recruitment of Effector T Cell Subsets

48. Anisakis pegreffii impacts differentiation and function of human dendritic cells

49. Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients

50. Immunological and Clinical Impact of Cancer Stem Cells in Vulvar Cancer: Role of CD133/CD24/ABCG2-Expressing Cells